BioAtla IPO Presentation Deck

BioAtla's Pioneering Work Yields Substantial IP Portfolio bicatla 257 Issued Patents 8 Allowed Patent Applications 214 Pending Patent Applications Note: Information as of December 2020 BioAtla's CAB Technology and Products Patent Coverage Worldwide patent coverage with issued and pending applications in all major market/manufacturing countries . Broad patent coverage including: methods of making and screening CAB antibodies different formats (e.g. ADC, multi- & bi-specific, CAR-T, mAbs and proteins) specific antibodies (composition of matter) Broad coverage provides a patent minefield where products are not dependent on a single patent for protection 28

View entire presentation